medAI Times

medAI Times
  • 0.0 (0)
  • Medicine
  • Updated Daily

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.

  1. Jul 27

    Should You Ask AI or Your Doctor? 2026 Evidence — Jul 27, 2026

    Chatbots beat doctors on paper. Then real patients used them and it fell apart. Run time: 6:50 In today's episode: Chatbot answers rated more empathetic than doctors, preferred 79% of the timeGPT-4 alone beat physicians by ~15 points on diagnostic vignettesGoogle's AMIE matched or beat primary care docs in text consultationsMicrosoft's system solved 85% of hard NEJM cases vs doctors' 20%Oxford RCT: patients using LLMs did no better than a web searchHalf of consumer chatbot medical advice carried potential for harm~1 in 6 US adults now use an AI chatbot for health advice monthlyTL;DR: On clean written cases, AI genuinely out-diagnoses doctors — that part is peer-reviewed, not hype.On real patients doing their own typing, that edge vanishes: an Oxford RCT (~1,300 people) found LLM users did no better than web search, because patients omit the detail that matters and models mix right advice with wrong.What's actually deployed is the opposite of a doctor replacement: clinician tools like OpenEvidence (used by ~65% of US doctors) keep a licensed human between the model and the prescription. No LLM is FDA-cleared to diagnose you solo.Sources cited: JAMA Internal Medicine, Ayers et al.JAMA Network Open, Goh et al.Nature, Google DeepMindMicrosoft AIOxford, Nuffield Dept of Primary Care (Payne et al.)NBC News on OpenEvidenceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  2. Jul 24

    ChatGPT Health Now Reads Your Medical Records — Jul 24, 2026

    Three hundred million health questions a week. Chat G P T just opened the doors. Run time: 7:11 In today's episode: ChatGPT Health opens to every US adultFDA lets Dexcom skip part of premarket reviewWhite House starts clinical AI benchmarking sprintNature Medicine RCT: eye AI lifts diagnosisUtah publishes AI prescription renewal dataMedtronic clears real-time AI for surgeryTempus buys Personalis for $1.5 billionEpic's AI leader joins an executive exodusAMD invests up to $5 billion in AnthropicAnthropic opens rare-disease research grantsOpenAI's test models breached Hugging FaceGoogle ships Gemini 3.6 Flash, still no 3.5 ProTL;DR: ChatGPT Health is now open to every US adult on every plan, connected to Epic and Oracle Health records, at 300 million health queries a week — with zero outcome evidence and a fresh lawsuit.Washington moved twice in one week: the FDA gave Dexcom the first premarket exemption under its TEMPO pilot in exchange for Medicare-generated real-world evidence, while OSTP, FDA and ONC opened a one-month sprint to define how clinical AI should be evaluated at all.The week's only top-tier randomized trial (Nature Medicine, July 24) worked because a clinician stayed in the loop: AI-assisted top-5 genetic accuracy 88.5% vs 67.3% for controls in inherited retinal disease.Sources cited: TechCrunchMedTech DiveSTATNature MedicineForbesMedtronicMedCity NewsSTATAMD/GlobeNewswireAnthropicSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  3. Jul 20

    How AlphaFold Changed Medicine: The 2026 Reality — Jul 20, 2026

    Two hundred million protein shapes, one Nobel Prize, and still zero A I drugs approved. Run time: 6:32 In today's episode: AlphaFold two hit ~90/100 accuracy at CASP14 (2020)Database now covers 214M+ protein sequences, 3M+ users2024 Nobel Prize: Hassabis, Jumper (AlphaFold) + Baker (design)AlphaFold3 predicts drug-protein binding, 58% vs 24% dockingStatic shapes only — fails on flexible, shape-shifting targetsZero AlphaFold-designed drugs approved; first trials targeted end-2026TL;DR: Real, at the research layer: AlphaFold solved a 50-year protein-shape problem (peer-reviewed, Nobel-confirmed) and put 214M+ free structures in front of 3M+ scientists in ~190 countries — it changed how medical research begins.Not yet, at the clinic: No AlphaFold-designed drug is approved or, as of spring 2026, even dosed in a patient; the models predict one static shape and stumble on the flexible drug targets that matter most.The milestone to watch: Isomorphic Labs (DeepMind spinout, $2.1B Series B) targets its first human cancer trials by end-2026 — that first-dose event, not the Nobel, is where "changed medicine" gets tested against outcome evidence.Sources cited: Nature 2021, Jumper et al.Nucleic Acids Research 2024, Varadi et al.Nature 2024, Abramson et al.EMBL-EBI resource updatePMC 2025, anti-schistosomal docking pipelinebioRxiv 2025, AlphaFold3 in Drug Discovery: capabilities & limitationsIsomorphic Labs, $2.1B Series B (May 2026)NobelPrize.org, Chemistry 2024Subscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  4. Jul 17

    Mayo Clinic Now Runs 150 AI Models — Jul 17, 2026

    Mayo Clinic is now running a hundred and fifty AI models at once. Run time: 6:48 In today's episode: Mayo Clinic now runs 150 AI modelsSenate probes Medicare Advantage AI care denialsSpecialized tool beats GPT, Gemini, ClaudeCausal AI: the vasopressor call decides survivalAI drugs pass safety, stall on efficacyNeuroVFM reads a hospital's own scansClaude adds self-serve HIPAA setupMoonshot's Kimi K3 lands at 2.8T paramsTL;DR: Mayo's 150 models plus a whistleblower suit show hospital AI's real fight has moved from capability to governance.The Senate and the HHS inspector general are closing in on Medicare Advantage AI denials, and the GOP just blocked a bid to kill the WISeR AI prior-auth pilot.Three peer-reviewed reads this week — OpenEvidence beating frontier LLMs, causal sepsis dosing, and the AI-drug Phase 2 wall — all land on the same point: a benchmark is not a bedside outcome.Sources cited: CNN Business (via KESQ)STATHealthcare DiveSTAT (WISeR vote)arXiv 2606.28960medRxiv 10.64898/2026.07.06.26357375Drug Discovery Today (2024)Nature MedicineAnthropic (release notes via Releasebot)LLM-Stats AI newsSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  5. Jul 13

    China vs US vs UAE: Who's Winning Healthcare AI? — Jul 13, 2026

    Three countries claim they're winning healthcare AI. None can prove it helps patients yet. Run time: 6:44 In today's episode: US leads on approvals: 1,400-plus FDA-cleared AI devicesChina leads on scale: DeepSeek live in 260-plus hospitalsUAE leads on data: ~1M genomes sequenced, open clinical LLMDeep Knowledge index (May 2026): US 1, UK 2, China 3The catch: almost none of it tied to patient outcomesTL;DR: There's no single winner — the US leads on capital, approvals, and frontier models; China leads on national-scale deployment; the UAE leads on genomic depth and sovereign data. Different races, different scoreboards.The headline numbers are inputs, not outcomes: FDA device counts, hospital deployments, genomes sequenced. None of the three has published randomized, outcome-level evidence that its AI makes patients live longer.China's flagship "Agent Hospital" 93% score is a simulation (AI treating AI-generated patients); America's ~1,400 clearances mostly ran the 510(k) resemblance pathway; the UAE's genome bank has few published clinical endpoints so far.Sources cited: FDA AI-Enabled Medical DevicesCKGSB KnowledgeGlobal TimesSemaformedRxiv preprintG42 / M42SCMP / Deep Knowledge GroupSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  6. Jul 10

    OpenAI Just Signed 8 Major Hospital Systems — Jul 10, 2026

    OpenAI just signed eight hospital systems the same week two studies said not so fast. Run time: 6:29 In today's episode: OpenAI signs eight major hospital systemsNHS deploys AI scribes to every A&ENature Medicine finds top medical models brittleKenya trial: AI helped notes, not patientsWeill Cornell agents design clinical trialsCardiac digital twin flags non-responders before implantPhilips gets FDA nod for AI ultrasoundMedicare launches new health-tech and AI officeClaude Cowork expands to web and mobileTL;DR: OpenAI is buying its way into hospitals — eight health systems signed, 230M weekly health users — but it's distribution, not clinical evidence.Two peer-reviewed papers this week undercut the hype: Nature Medicine shows flagship models are brittle under simple adversarial tweaks, and a Kenyan RCT shows an AI helper improved notes but not patient outcomes.The at-scale wins remain operational, not diagnostic: NHS ambient scribes save ~47 min/shift; Philips' new FDA-cleared ultrasound automates measurement, not diagnosis.Sources cited: ForbesNHS EnglandNature MedicineNature MedicineWeill CornellmedRxivPhilipsHealthcare DiveTechCrunchAxiosSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  7. Jul 6

    Will AI Replace Radiologists? What the Evidence Says — Jul 6, 2026

    Ten years ago an AI pioneer said stop training radiologists. The field grew instead. Run time: 5:40 In today's episode: Hinton's 2016 "stop training radiologists" call has now expiredOn narrow tasks, AI beats radiologists on average (AUC 0.88)A workforce model projects a ~33% cut in radiologist hours over 5 yearsBut models crater on external data and disagree with each otherHuman + AI beats AI alone in every head-to-headAutonomy is live only for auto-clearing normal chest X-raysVerdict: the job is being rearranged, not deletedTL;DR: The strong claim ("AI replaces radiologists") is pundit/vendor tier; the peer-reviewed and prospective data consistently show human-plus-AI beating AI alone, with autonomy confined to triaging normal studies.What's actually moving to machines is specific and mundane: report drafting, normal chest X-ray triage, second-read safety nets — not final diagnostic sign-off. Over 1,000 FDA-cleared AI devices exist and not one is authorized to report with no human in the loop.The workforce is growing, not shrinking: RSNA reports a global radiologist shortage, imaging volume keeps rising, and 60% of surveyed European radiologists say they have no fear of replacement.Sources cited: Multi-target AI, 16 findings on chest/abdominal CTThe Effect of AI on the Radiologist Workforce: A Task-Based AnalysisSystematic review of AI generalizability across clinical settingsSeven commercial lung-cancer CXR tools head-to-head, Radiology (RSNA)Standalone AI vs AI-assisted radiologists for intracranial hemorrhageNature Medicine, "How to meaningfully evaluate AI in clinical medicine"India multicenter QIUK service evaluationThe role of AI in mitigating radiologist shortages (systematised review)NEJM AI automation-bias RCTSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

  8. Jul 3

    Fable 5 Is Back After the US Lifts Anthropic's AI Ban — Jul 3, 2026

    The most powerful AI the US banned last month is back — and biomedical labs want it. Run time: 5:33 In today's episode: US lifts export ban; Fable 5, Mythos 5 back worldwideAnthropic launches Claude Science for pharma researchClaude Sonnet 5 ships: near-Opus quality, cheaperFDA clears on-premise brain-tumor MRI AI (Cercare)GE HealthCare clears auto-contouring for radiation therapyFeds reprimand AI Medicare prior-auth pilot (WISeR)Qualified Health raises $125M for hospital AINVIDIA's surgical robotics foundation models advanceTL;DR: The US reversed its June 12 export ban: Anthropic's Fable 5 and Mythos 5 are back worldwide as of July 1 with a new safety classifier — restoring the drug-design model biomedical labs relied on. Access restored, not efficacy proven.Anthropic doubled down on medicine the same week: Claude Science (a research workbench aimed at pharma) and Claude Sonnet 5 (near-Opus quality at $2/$10 per Mtok) both launched June 30.Two FDA imaging clearances (Cercare's on-premise brain-tumor segmentation; GE's radiation-therapy auto-contouring) and one federal reprimand of an AI Medicare prior-auth contractor round out the week — capability moving forward, oversight catching up.Sources cited: Al JazeeraSTATAuntMinnieAuntMinnieKUOWFierce HealthcareAnthropicAxiosNVIDIA / Hugging FaceSubscribe: YouTube medAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.

See All (28)

About

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health. Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype. New episodes daily. For educational and informational purposes only. Not medical advice.

Information

  • Creator
    medAI Times
  • Years Active
    2026
  • Episodes
    28
  • Rating
    Clean
  • Copyright
    © 2026 medAI Times
  • Show Website
    medAI Times